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Summary
Background Evidence on the optimal time to initiation of complementary feeding in preterm infants is scarce. 
We examined the effect of initiation of complementary feeding at 4 months versus 6 months of corrected age on 
weight for age at 12 months corrected age in preterm infants less than 34 weeks of gestation.
Methods In this open-label, randomised trial, we enrolled infants born at less than 34 weeks of gestation with no major 
malformation from three public health facilities in India. Eligible infants were tracked from birth and randomly 
assigned (1:1) at 4 months corrected age to receive complementary feeding at 4 months corrected age (4 month group), or 
continuation of milk feeding and initiation of complementary feeding at 6 months corrected age (6 month group), using 
computer generated randomisation schedule of variable block size, stratified by gestation (30 weeks or less, and 
31–33 weeks). Iron supplementation was provided as standard. Participants and the implementation team could not be 
masked to group assignment, but outcome assessors were masked. Primary outcome was weight for age Z-score at 
12 months corrected age (WAZ12) based on WHO Multicentre Growth Reference Study growth standards. Analyses were 
by intention to treat. The trial is registered with Clinical Trials Registry of India, number CTRI/2012/11/003149.
Findings Between March 20, 2013, and April 24, 2015, 403 infants were randomly assigned: 206 to receive 
complementary feeding from 4 months and 197 to receive complementary feeding from 6 months. 22 infants in the 
4 month group (four deaths, two withdrawals, 16 lost to follow-up) and eight infants in the 6 month group (two deaths, 
six lost to follow-up) were excluded from analysis of primary outcome. There was no difference in WAZ12 between 
two groups: –1·6 (SD 1·2) in the 4 month group versus –1·6 (SD 1·3) in the 6 month group (mean difference 0·005, 
95% CI –0·24 to 0·25; p=0·965). There were more hospital admissions in the 4 month group compared with the 
6 month group: 2·5 episodes per 100 infant-months in the 4 month group versus 1·4 episodes per 100 infant-months 
in the 6 month group (incidence rate ratio 1·8, 95% CI 1·0–3·1, p=0·03). 34 (18%) of 188 infants in the 4 month 
group required hospital admission, compared with 18 (9%) of 192 infants in the 6 month group. 
Interpretation Although there was no evidence of effect for the primary endpoint of WAZ12, the higher rate of hospital 
admission in the 4 month group suggests a recommendation to initiate complementary feeding at 6 months over 
4 months of corrected age in infants less than 34 weeks of gestation.
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salary was supported for 2 months by an institute fellowship from All India Institute Of Medical Sciences, and a grant 
by Wellcome Trust thereafter. 
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Introduction
Exclusive breastfeeding for 6 months followed by 
complementary feeding for term infants is a standard 
recommendation by WHO, widely endorsed and 
accepted by the global community. However, none of the 
organisations including WHO,1 the European Society of 
Paediatric Gastroenterology, Hepatology and Nutrition 
(ESPGHAN),2 or the American Academy of Pediatrics3 
provide evidence-based guidelines with respect to the 
optimal time of initiation of complementary feeding in 
preterm infants who are at a much higher risk of 
postnatal growth restriction than full-term infants.4,5 The 
only available guidelines are from the UK, and are based 
on a single, non-systematic review of primarily 
physiological studies.
Extrapolating the recommendation for full-term 
infants to initiate complementary feeding at 6 months of 
age to preterm infants is dependent on two major 
questions: what does 6 months refer to in a preterm 
infant—chronological (postnatal) age or corrected age? 
Health-care providers generally use corrected age for 
monitoring the physical growth and development of 
preterm infants. Secondarily, if we assume that 6 months 
refers to the corrected age, should these infants not start 
complementary feeding earlier than their full-term 
counterparts—for example, at 4 months corrected age 
Lancet Glob Health 2017; 
5: e501–11
See Comment page e470
*A complete list of the 
investigators of the CF trial is 
included at the end of the article
All India Institute of Medical 
Sciences, Delhi, India 
(S Gupta MD, R Agarwal DM, 
A Duggal MD, S Bhatia DCH, 
M J Sankar DM, V Sreenivas PhD, 
V Jain MD, A K Gupta MD, 
A K Deorari MD, V K Paul MD); 
Vardhman Mahavir Medical 
College and associated 
Safdarjung hospital, New 
Delhi, India (K C Aggarwal MD, 
H Chellani MD, S Arya MD); and 
Kasturba Hospital , Delhi, India 
(A Duggal, S Bhatia)
Correspondence to: 
Dr Ramesh Agarwal, Department 
of Pediatrics, All India Institute of 
Medical Sciences, Delhi 110029, 
India 
ra.aiims@gmail.com
or
Dr Harish Chellani, Department of 
Pediatrics, Vardhman Mahavir 
Medical College and associated 
Safdarjung hospital, Delhi, 
110029, India
Articles
e502 www.thelancet.com/lancetgh   Vol 5   May 2017
instead of 6 months corrected age (appendix p 1)? 
Preterm infants have higher energy requirements 
compared with full-term infants,6,7 and it is not known 
how long in infancy milk feeds alone (breastmilk or 
formula) are sufficient to meet their requirements. Most 
complementary foods provide higher calorie density 
compared with milk feeds, and can make up for the 
energy gap between increased requirements of preterm 
Research in context
Evidence before this study
We searched MEDLINE and Cochrane Central Register of 
Controlled Trials (CENTRAL) up to 6 Feb 2016, limited to 
human studies but with no restriction of language or 
publication date, using the terms “complementary food” 
OR “complementary foods” OR “complementary feeding” 
OR “supplementary feeding” OR “weaning” OR “weaning 
foods” OR “beikost” OR “semisolids” OR “semisolid foods” OR 
“semisolid food” OR “semisolid feeds” OR “infant feeding” OR 
“infant diet” OR “infant food” OR “infant foods”. We found 
22723 articles on MEDLINE and 3667 on CENTRAL. After 
screening the title and abstracts and excluding duplicates, we 
reviewed the full text of 50 potentially relevant studies. We 
also searched the reference list of all these 50 studies to 
identify any other relevant studies.
Inclusion criteria for the Review were: any randomised, 
quasi-randomised trial or observational study investigating 
different time or age at initiation or introduction of 
complementary feeding in preterm infants. Complementary 
feeding was defined as initiation of semisolid, soft or solid 
foods other than breast, formula, or animal milk. We therefore 
excluded any studies enrolling full term infants or those where 
the term ‘weaning’ was used to indicate transition from 
breastfeeding to formula or animal milk rather than to 
semisolid, soft, or solid foods.
On full text review and reference list search, we identified three 
studies eligible for this Review—one randomised trial, 
one prospective observational study and one study that was a 
secondary analysis of data from original unrelated studies. 
The first study randomly assigned all preterm infants of less 
than 37 completed weeks gestation (n=68) to receive 
complementary feeding after 13 weeks of postnatal age if 
weighing at least 3·5 kg; or after 17 weeks of postnatal age if 
weighing at least 5·0 kg. The intervention, ie, initiation of 
complementary feeding in both groups, was also subject to 
parental perception of infant being ready to accept 
complementary feeding. The 13 week group also received a 
co-intervention in the form of energy and protein-dense food. 
The study did not find any significant difference in the SDs of 
length (0·2, 0·2 vs –0·1, 0·3), weight (–0·7, 0·2 vs –0·8, 0·2) and 
head circumference (–0·5, 0·2 vs –0·5, 0·2) between the groups. 
However, there was some improvement in length gain per week 
from birth to 12 months corrected age (mean cm per week, 
SD: 5·1, 0·07 vs 4·9, 0·10; p=0·04) and change in mean length 
SDs in the early weaning group (mean, SD: –1·1, 0·2 at birth to 
0·2, 0·2 at 12 months corrected age) when compared with late 
weaning group (mean, SD: –1·0, 0·2 at birth to –0·1, 0·3 at 
12 months corrected age).
The second study followed preterm infants from birth until 
12 months corrected age, and recorded the time of initiation 
of complementary feeding based on information on 
introduction of 12 prelisted food items. Introduction of 4 or 
more items (n=203 infants) compared with that of less than 
4 items (n=54 infants) by 17 weeks corrected age was 
associated with 3·5 times higher risk for developing eczema at 
12 months corrected age.
The third study was a secondary analysis of data with respect to 
introduction of solid foods at ≤12 weeks or >12 weeks on growth 
parameters of preterm infants, from two previous trials—one on 
post-discharge formula vs full term formula (published), and 
another unpublished. The study did not find any difference with 
regard to introduction of solid foods ≤12 weeks or >12 weeks on 
weight gain in kg (mean, SE: 8·25, 0·05; n=365 vs 8·27, 0·07; 
n=102), length gain in cm (70·3, 0·16; n=362 vs 70·6, 0·2; 
n=102) and head circumference gain in cm (45·8, 0·08; n=364 vs 
45·8, 0·12; n=102) between 12 weeks and nine months corrected 
age, or between 12 weeks and 18 months corrected age (data 
not reported). There was no difference in the prevalence of atopy, 
lower respiratory tract infection, gastroenteritis, sleep duration, 
or waking at night between the two groups.
Added value of this study
Our study provides level-1 evidence with regard to the timing 
(4 vs 6 months of corrected age) for initiation of complementary 
feeding in preterm infants less than 34 weeks of gestation, a 
group most susceptible to postnatal growth restriction. It shows 
that early initiation of complementary feeding at 4 month 
compared with 6 months of corrected age does not improve 
growth of preterm infants at corrected age of 12 months. It also 
does not result in a difference in neurodevelopment outcomes, 
body composition, bone mineralisation, and any marker for 
metabolic syndrome like insulin resistance, lipid profile, and blood 
pressure in infancy. Rather, earlier initiation of complementary 
feeding at 4 months corrected age increases the risk of hospital 
admission due to concurrent morbidities, predominantly 
diarrhoea and lower respiratory tract infections. In both groups, 
dietary patterns remain poor and body iron stores remain 
depleted despite iron supplementation until 12 months of 
corrected age.
Interpretation
Our study suggests that 6 months of corrected age should be 
preferred over 4 months of corrected age for initiation of 
complementary feeding in preterm infants less than 34 weeks 
of gestation. Findings of clinically significant iron deficiency 
despite iron supplementation and poor dietary patterns in 
infancy will guide further research.
See Online for appendix
Articles
www.thelancet.com/lancetgh   Vol 5   May 2017 e503
infants, and limited supply from milk feeds. Therefore, 
an earlier introduction of complementary feeding in 
preterm infants than is recommended for full-term 
infants might help improve their growth.
We did a systematic review to answer this crucial 
question but found only one low quality randomised trial 
addressing the issue.8 We therefore chose to test the 
hypothesis that initiation of complementary feeding 
(defined as semisolid, soft, or solid foods other than 
breastmilk, formula, or animal milk) at 4 months 
compared with 6 months corrected age in infants less 
than 34 weeks of gestation will increase their weight for 
age Z-score at 12 months corrected age (WAZ12) by 
0·5 standard deviation score (SDS; around 500 g, based 
on WHO-Multicentre Growth Reference Study [MGRS] 
growth standards).9 We also investigated neuro-
development, body composition, bone density, and early 
markers of metabolic syndrome as there is little evidence 
on the links between infant feeding and later health, and 
sought to characterise potential effects of the nutritional 
intervention on some markers of the same.
Methods
Study design
We did this randomised, open-label, parallel group trial 
at three public health facilities; the All India Institute of 
Medical Sciences (AIIMS), Vardhman Mahavir Medical 
College associated Safdarjung hospital, and Kasturba 
hospital in New Delhi, India. All three sites provide 
tertiary care neonatal services to inborn neonates. 
Neonatal intensive care is provided to all infants less than 
34 weeks of gestation, and exclusive breastmilk feeding is 
actively promoted (appendix p 2). Ethics approval was 
obtained from institutional ethics committees at all sites. 
The trial is registered with Clinical Trials Registry of 
India, number CTRI/2012/11/003149.
Participants
Eligible patients were infants less than 34 weeks of 
gestation with no major malformation, residing within 
60 km of study hospitals and not expected to move away 
from the study region within 1 year of birth. Infants 
requiring hospital admission from birth to later than 
40 weeks postmenstrual age were excluded. Research 
team identified potentially eligible infants at birth, kept 
them in follow-up after discharge and called their 
caregiver by telephone at 4 months corrected age for 
enrolment into the study. Infants were excluded at this 
stage if they had already been started on complementary 
feeding. Initiation of complementary feeding was 
defined as intentional initiation of complementary food 
by family irrespective of amount, unintentional initiation 
but food given for more than 3 days, or that the total 
amount given provided more than 1% of recommended 
dietary allowance of calories for the infant. Written 
informed consent was obtained from the parents or 
legally acceptable representative.
Randomisation and masking
Participants were randomly assigned (1:1 allocation) to 
the 4 month group, wherein parents or family were 
advised to initiate complementary feeding at 4 months 
corrected age; or to the 6 month group, in which they 
were advised to continue milk feeds until 6 months 
corrected age, followed by initiation of complementary 
feeding at 6 months corrected age. An independent 
person (MJS) provided computer generated random 
sequences, stratified for site and gestation (30 weeks or 
less and 31–33 weeks) with variable block size unknown 
to the research team involved in implementation. 
Allocation was concealed using sealed, opaque, 
sequentially numbered envelopes. The families and 
research team involved in implementation could not be 
masked to the allocation groups following randomisation, 
however, those assessing primary and secondary 
outcomes were masked. Twins and triplets were assigned 
to the same group.
Procedures
Detailed descriptions of the study procedures can be 
found in the appendix (p 3). At 4 months corrected age, 
we randomly assigned the infants and did baseline 
anthropometric measurements and Dual Energy X-Ray 
Absorptiometry (DXA).
A single person counselled the families for initiation of 
complementary feeding at corrected age 4 months or 
6 months, using uniform, prerecorded audio-visual 
counselling instructions in local language. The 
instructions were based on the WHO guidelines on 
complementary feeding of the breastfed child,1 and 
specified the desired frequency, amount, consistency, 
and texture of food, and principles of responsive feeding, 
hygiene, feeding during and after illness, and 
maintenance of breastfeeding. In the audio-visual 
presentation, we also included a demonstration on 
cooking common recipes of the region, which were 
prepared and standardised in terms of energy and other 
nutrient densities in accordance with the WHO 
guidelines. Additionally, families’ queries were resolved 
through one-to-one counselling. The mothers were 
provided a handout of the instructions and suggested 
recipes in local language, and a set of uniform household 
utensils with known capacity to measure the ingredients 
and to feed the child.
We asked mothers to maintain a daily dietary record 
incorporating information on type, frequency and amount 
of food consumed by the child, and problems faced, if any. 
Mothers maintained this record for 4 weeks beginning 
from date of counselling for initiation of complementary 
feeding. We reinforced at each visit the supplementation 
of the infants with vitamin D (400 IU per day) and 
elemental iron (2–3 mg/kg per day), which was started 
from 2 weeks of age as part of the study hospitals’ clinical 
policy. Subsequently, we called the infants for hospital 
visit at corrected age 5, 6, 7, 9, and 12 months to measure 
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anthropometry, morbidity inquiry, and 24 hour dietary 
recall (appendix p 4). Additionally, we provided families in 
both groups with 24-h, 7-day per week need-based 
telephone support. At the 12 month visit, we did 
neurodevelopmental assessments, DXA, and fasting 
blood sampling as part of final outcome assessment. If an 
infant could not be brought to the hospital, the study team 
made a home visit to measure outcomes, except blood 
sampling and DXA. We measured compliance to 
intervention through telephone calls made on days 2, 7, 
14, 21, and 28 at 4 months and again at 6 months of 
corrected age in both groups, which was also corroborated 
by the daily dietary record maintained by the mothers.
We defined infants as receiving allocated intervention 
if they were offered complementary feeding within 4 weeks 
of counselling for initiation of food, irrespective of 
amount consumed. An additional criterion in the 
6 month group was that if complementary feeding was 
started before the scheduled 6 months corrected age, it 
should not have been started more than a week before 
6 months corrected age. The intrauterine growth category 
at birth and the Z scores for weight, length, and head 
circumference at birth, discharge, and 40 weeks of 
postmenstrual age were based on revised Fenton’s 
charts 2013,10 calculated using the provided 
anthropometric software for research data. Nutrient 
intakes were calculated from 24 dietary recalls using the 
nutritive value of Indian foods.11 We also calculated 
important dietary indicators related to infant feeding at 
9 and 12 months of age based on the information 
recorded during the 24-hour dietary recalls based on 
WHO definitions (appendix p 4).12 We also noted the 
consistency and texture of food, which was based on 
expert assessment due to absence of standard criteria. 
Z scores for weight, length, head circumference, weight 
for length, and body–mass index at subsequent 
timepoints, (ie, 4, 5, 6, 7, 8, 9, and 12 months corrected 
age) were calculated using WHO-MGRS growth 
standards.9
Outcomes
The primary outcome was WAZ12, based on WHO-MGRS 
growth standards.9 The infant was weighed using an 
electronic weighing scale (Seca, Germany; accuracy 5 g) 
and the weight was converted into respective Z score 
using WHO Anthropometric software (version 3.2.2, 
2011), using corrected age. Secondary outcomes were any 
morbidity requiring hospital admission from the 
time of enrolment until 12 months corrected age, 
neurodevelopment, body composition, bone mineral 
content (BMC) and bone mineral density (BMD), insulin 
resistance in terms of HOMA-IR (HOmeostatic Model 
Assessment for Insulin Resistance), lipid profile, blood 
pressure, and serum ferritin at 12 months corrected age. 
Hospital admission was defined as admission to an 
inpatient facility for duration of 6 h or more or as 
inpatient death irrespective of duration of admission. A 
paediatrician verified the diagnosis for each episode by 
reviewing the case records and interaction with the 
treating physician where required. Repeat hospital 
admissions for an infant should have been separated by 
more than a week to count as separate episodes. 
Neurodevelopment was assessed by a single certified 
clinical psychologist using Developmental Assessment 
Scale for Indian Infants (DASII), a validated Indian 
adaptation of Bayley-II.13 Whole body composition, BMC, 
and BMD were assessed using DXA (Hologic 
DISCOVERY W, S/N 84879, version 13.1.1:7; software 
Apex Version 3.0). HOMA-IR was calculated using the 
formula:14
Fasting (minimum 4 h) plasma glucose was measured by 
Enzymatic Colorimetric Test Method (GOD-PAP method) 
without deproteinisation based on enzyme glucose 
oxidase, using Glucose PAP Fluid Mono reagent 
(Centronic GmBH, Germany), on ROCHE Modular P-800 
fully automatic analyser. Serum insulin and ferritin were 
measured by electrochemiluminescence immunoassay 
(ECLIA) using RocheCobase411 (Roche Diagnostics, 
Germany). A value of serum ferritin less than 12 was 
taken as cutoff for depleted iron stores.15 For lipid profile, 
fasting total cholesterol and triglycerides were assessed 
using enzymatic methods and high density lipoprotein by 
direct method, on ROCHE P-800 fully automatic analyser. 
Very low density lipoprotein was calculated using 
triglyceride value and low density lipoprotein was 
calculated using total cholesterol, high density lipoprotein, 
and triglyceride values using Friedewald equation.16 Blood 
pressure was measured using arm-type fully automatic 
digital blood pressure monitor (AG-SafeCHEK™, model 
AG1010; accuracy 3 mm Hg), based on the oscillometric 
method, using reusable blood pressure cuff (WelchAllyn® 
Flexiport™ infant size number 7). Additionally, serum 
C-reactive protein was measured using high sensitivity 
C- reactive protein Enzyme Immunoassay (BioCheck, 
USA). This was done to better reflect on the value of 
serum ferritin, which is also an acute phase reactant.
Statistical analysis
We based our sample size estimates on the data on 
WAZ12 for infants less than 34 weeks of gestation from a 
birth cohort study of preterm infants from our own unit, 
which measured growth outcomes using WHO-MGRS 
growth standards,16 prospectively at 3 monthly intervals 
from birth till 18 months of age (WAZ12: 1·7 ± 1·5, n=15; 
personal communication, Sharma P).17 Assuming an 
effect size of 0·5 SDS, β of 0·9, and a two-sided α of 0·05, 
the sample size was 190 in each group. Accounting for 
5% loss to follow-up, total sample size was calculated 
fasting insulin (μU/mL) 
× fasting glucose (mmol/L)
HOMA-IR = 
22·5
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to be 400. The calculated sample size was further 
corroborated through a pilot study (infants in pilot phase 
were not included in this study).
Data were entered in duplicate in an online database 
developed in Visual Basic as front-end and MS SQL server 
as back-end with inbuilt range and logical checks, with 
audit trail. Analysis was done using STATA 11·0 (College 
Station, TX, USA), by intention to treat. Continuous 
variables were compared using Student t test for normally 
distributed and Wilcoxon rank-sum for non-normally 
distributed data. Proportions were compared using 
chi-square test. We constructed a Kaplan-Meir survival 
curve to depict the first episode of hospital admission in 
each group during the study period including available 
information on all infants, and calculated the hazard ratio 
between the two groups using Cox proportional hazard 
regression. We also used the Anderson-Gill model, which 
is counting process extension for Cox proportional hazard 
2135 livebirths at less than 34 weeks gestation
206 allocated to receive complementary feeding at 4 months corrected age 197 allocated to receive complementary feeding at 6 months corrected age
184 analysed for primary outcome 189 analysed for primary outcome
1677 potentially eligible at birth
1089 discharged
412 eligible at 4 months corrected age
403 enrolled
403 randomised
429 ineligible
 344 residence >60 km from facility
 68 major malformation or congenital infection
 2 planned to move away
 15 required hospital admission for more than 40 weeks 
  post-menstrual age
 29 other exclusions
 5 unreliable gestation
 2 medico-legal case
 1 mother psychiatric patient
 16 left against medical advice
 5 refused follow-up at facility
 114 died
 35 already started on complementary food
 140 permanently moved away
 102 unable to follow up at facility
 30 not contactable
 1 operation for Hirschsprung disease
 2 congenital hydrocephalus
 1 toxoplasmosis
 11 congenital heart disease
 1 under work-up for biliary atresia
 1 syndromic
 3 accident
 3 given for adoption
 4 admitted to hospital at time of enrolment
 1 infant on orogastric feeds
 6 family or social reasons
 3 missed appointment
 1 mother sick at time of enrolment
 218 less than 4 months corrected age at end of enrolments
578 died
 5 transferred to another ward
 5 admitted at the time of concluding enrolments
7 did not receive allocated intervention
 5 started complementary feeding between 5 and 6 months
 1 started complementary feeding between 6 and 7 months
 
9 refused consent
9 did not receive allocated intervention
 1 started complementary feeding earlier
 2 started complementary feeding between 7 and 9 months
 5 started complementary feeding between 9 and 12 months
22 excluded from primary outcome analysis
 2 withdrew consent
 16 lost to follow-up
 4 died
8 excluded from primary outcome analysis
 2 died
 6 lost to follow-up
Figure 1: Trial profile
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regression to calculate the hazard ratio between the 
two groups to account for multiple episodes of hospital 
admission for any infant.
A prespecified subgroup analysis was done by site, 
intrauterine fetal growth category (small-for-gestational-age, 
appropriate-for-gestational-age), gestational age at birth 
(<28 weeks, 28–30 weeks and 31–33 weeks), and type of 
feeding at randomisation (breastfed, non-breastfed, mixed 
fed). Generalised estimating equation analysis was used to 
compare anthropometry trend between the two random 
groups over time. We accounted for the clustering effect on 
the primary outcome due to corandomisation of twins and 
triplets by reanalysing the primary outcome after dropping 
multiple births (retaining first twin only) in both groups. 
Study was supervised by an independent Doctoral 
Committee that reviewed the processes every 6 months. An 
independent safety adviser also reviewed the data on 
mortality and morbidity.
Role of funding source
The Indian Council of Medical Research had no role in 
study design, data collection, analysis, interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
Between March 20, 2013, and April 24, 2015, we identified 
2135 livebirths at less than 34 weeks gestation. 412 were 
eligible at 4 months corrected age, nine of whom refused 
consent, and 403 were randomly assigned—206 infants 
to the 4 month group and 197 infants to the 6 month 
group (figure 1). Overall, a total of 22 infants in the 
4 month group (a pair of twins had consent withdrawn, 
16 infants were lost to follow-up, and four died) and 
eight infants in the 6 month group (six infants were lost 
to follow-up and two died) were excluded from the 
analysis of the primary outcome. However, deaths were 
included in the analysis as secondary outcome.
196 of 203 infants in the 4 month group (two withdrew 
consent, one died before complementary feeding could 
be initiated) and 184 of 193 infants in the 6 month group 
(two died and two lost to follow-up before complementary 
feeding could be initiated) received the allocated 
intervention.
The baseline characteristics of study infants at birth 
and at randomisation were similar (table 1). Mean age at 
randomisation was 3·9 months corrected age in both the 
groups, and mean weight and WAZ were 5117 g in the 
4 month group versus 5187 g in the 6 month group and 
–2·3 in the 4 month group versus –2·2 in the 6 month 
group. The proportion of infants receiving any 
breastfeeding was similar between two groups at all 
timepoints (appendix p 5). A high proportion of infants 
were receiving complementary feeding (irrespective of 
amount) 1 month after counselling for initiation of food 
(95·4% vs 90·7%; appendix p 5).
4 month group (n=204) 6 month group (n=197)
Maternal age, years (SD) 26·9 (4·9) 26·4 (4·1)
Paternal age, years (SD) 30·5 (5·5) 30·1 (4·7)
Maternal education
Professional, graduate, post-graduate 58 (28·5%) 44 (22·3%)
Intermediate, post-secondary diploma, high school 68 (33·3%) 72 (36·6%)
Middle, primary 61 (29·9%) 55 (27·9%)
Illiterate 17 (8·3%) 26 (13·2%)
Family income , thousand Indian rupees per month 
(IQR)
10 (7–15) 10 (8–15)
Infant characteristics at birth
Gestation, weeks (SD) 31·7 (1·4) 31·5 (1·7)
Gestation category
<28 weeks 4 (2·0%) 6 (3·1%)
28–31 weeks 66 (32·4%) 68 (34·5%)
32–33 weeks 134 (65·7%) 123 (62·4%)
Birthweight, g (SD) 1479 (308) 1492 (344)
Birthweight Z score (based on weight for gestational 
age at birth)*
–0·84 (0·71) –0·73 (0·76)
Birthweight category
<1000 g 13 (6·4%) 13 (6·6%)
1000–1499 g 79 (38·7%) 77 (39·1%)
≥1500 g 112 (54·9%) 107 (54·3%)
Small for gestational age* 58 (28·4%) 54 (27·4%)
Multiple births 55 (27·0%) 48 (24·3%)
Female sex 109 (53·4%) 93 (47·2%)
Antenatal steroids received 169 (85·4%) 169 (86·2%)
Duration of NICU stay, days (IQR) 7 (4–12) 6 (4–12)
Infant characteristics at randomisation
Corrected age (months) 3·9 (0·1) 3·9 (0·1)
Weight (g) 5117 (906) 5187 (928)
Weight for age (Z score) –2·3 (1·4) –2·2 (1·4)
Length (cm) 58·5 (3·1) 58·6 (3·2)
Length for age (Z score) –2·0 (1·4) –2·0 (1·5)
Head circumference (cm) 38·9 (1·6) 39·0 (1·4)
Head circumference for age (Z score) –1·7 (1·2) –1·7 (1·2)
Weight for length Z score –0·96 (1·1) –0·9 (1·1)
BMI (kg/m²) 8·7 (1·2) 8·8 (1·2)
BMI for age Z score –1·5 (1·2) –1·5 (1·2)
Body composition
Fat mass (g) 1259 (746), n=166 1242 (662), n=149
Lean�+�BMC mass (g) 4346 (836), n=166 4462 (715), n=149
Total mass (g) 5624 (965), n=166 5690 (985), n=149
Percent fat (%) 21·7 (11·2), n=166 21·1 (9·3), n=149
BMC (g) 95·7 (24·6), n=173 93·8 (23·0), n=156
Bone mineral density (g/cm2) 0·170 (0·028), n=173 0·167(0·022), n=156
Method of feeding
Only breastfeeding 104 (51·2%) 98 (49·8%)
Mixed feeding (breastmilk and animal or 
formula milk)
61 (30·1%) 55 (27·9%)
Exclusively top-fed 
(no breastfeeding, only animal or formula milk)
38 (18·7%) 44 (22·3%)
Data are n/N(%), or mean (SD), unless otherwise specified. NICU=neonatal intensive care unit. BMI=body–mass 
index. BMC=bone mineral content. *Using Fenton growth charts 2013.
Table 1: Baseline characteristics
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The primary outcome, WAZ12, was similar between the 
two groups (mean –1·6, SD 1·2 in the 4 month group 
vs –1·6, 1·3 in the 6 month group; mean difference 0·005, 
95% CI –0·24 to 0·25; p=0·96) at mean corrected age of 
12·2 months (table 2). The change in WAZ in study infants 
from birth until 12 months corrected age (p=0·61; figure 2) 
and specifically between 4 and 12 months of corrected age 
was similar (p value on generalised estimating equation 
4 month group 6 month group Mean difference or risk ratio 
(95% CI)
p value
Primary outcome
Weight for age (Z score) –1·6 (1·2), n=184 –1·6 (1·3) n=189 0·005 (–0·24 to 0·25) 0·965
Secondary outcomes
Death 4/203* 2/197 1·9 (0·4 to 10·5) 0·685
Hospital admission
Infants, n (%)† 34/188 (18·1%) 18/192 (9·4%) 1·9 (1·1 to 3·3) 0·014
Episodes per infant-month (IR) 39/1590 (0·025) 23/1606 (0·014) 1·7 (1·0 to 3·0)‡ 0·039
Diagnosis
Diarrhoea (with or without 
dehydration)
11 6 ·· ··
LRTI 16 11 ·· ··
Both diarrhoea and LRTI 1 1 ·· ··
Sepsis 3 1 ·· ··
Other 7 3 ·· ··
Unclear 1 1 ·· ··
Neurodevelopment
MoDQ50 84·0 (15·4), n=182 83·8 (14·0), n=184 0·2 (–2·9 to 3·2) 0·918
MoDQ50<70 27 (14·8%), n=182 22 (12·0%), n=184 1·2 (0.7 to 2.1) 0·552
MoDQ97 104·3 (18·6), n=182 102·6 (16·8), n=184 1·7 (–1·9 to 5·4) 0·351
MeDQ50 89·0 (12·4), n=181 89·2 (11·5), n=184 –0·3 (–2·8 to 2·1) 0·786
MeDQ50<70 12 (6·6%), n=181 12 (6·6%), n=182 1·0 (0.5 to 2.2) 0·713
MeDQ97 108·7 (18·4), n=181 109·0 (14·9), n=184 –0·2 (–3·7 to 3·2) 0·893
Body composition
Fat mass (g) 2056 (714), n=134 2128 (762), n=135 –72 (–250 to 105) 0·423
Lean + BMC mass (g) 6182 (805), n=134 6265 (922), n=135 –84 (–292 to 124) 0·428
Total mass (g) 8234 (1129), n=134 8427 (1208), n=135 –193 (–474 to 88) 0·178
Percent fat (%) 24·5 (6·8), n=134 25·3 (6·7), n=135 –0·8 (–2·4 to 0·8) 0·329
BMC(g) 186·0 (35·7), n=135 191·8 (32·9), n=135 –5·7 (–13·9 to 2·5) 0·173
Bone mineral density (g/cm2) 0·25 (0·03), n=135 0·25 (0·03), n=135 –0·001 (–0·008 to 0·006) 0·770
Lipid profile (mg/dL)
Total cholesterol 141·4 (33·1), n=161 141·8 (32·9), n=173 –0·4 (–7·5 to 6·7) 0·919
Triglycerides 123·4 (61·6), n=160 125·1 (67·8), n=173 –1·6 (–15·6 to 12·4) 0·818
HDL 37·9 (12·3), n=161 38·3 (12·1)  n=173 –0·4 (–3·1 to 2·2) 0·758
LDL 77·3 (27·9), n=160 76·8 (28·0), n=172 0·5 (–5·5 to 6.5) 0·870
VLDL 25·8 (12·1), n=160 26·3 (13·7), n=173 –0·5 (-3·3 to 2·3) 0·731
HOMA-IR* 0·4 (0·3–0·7), n=153 0·4 (0·2–0·7), n=166 .. 0·675
Blood pressure (mm Hg)
Systolic 80·9 (6·6), n=135 80·9 (6·2), n=149 0·05 (–1·4 to 1·5) 0·951
Diastolic 50·1 (5·8), n=135 50·4 (5·3), n=149 –0·3 (–1·6 to 1·0) 0·632
Serum ferritin (µg/dL ) 5·4 (3·2–12·4), n=160 5·7 (2·5–13·3), n=173 ·· 0·732
Serum ferritin <12 µg/dL, n (%) 119/160 (74·4%) 126/173 (72·8%) 1·0 (0·9 to 1·2) 0·750
Data are mean (SD), n/N (%), or median (IQR). p values are from Fisher-exact test, t-test, Wilcoxon rank-sum or χ² test. IR=incidence rate. LRTI=lower respiratory tract infection. 
MoDQ50=motor developmental quotient–50th centile. MoDQ97=motor developmental quotient–97th centile. MeDQ50 =mental developmental quotient–50th centile. BMC=bone 
mineral content. VLDL=very low density lipoprotein. HOMA-IR=Homeostatic Model Assessment for Insulin Resistance.*Outcome of death was known for all enrolled infants 
except for one infant in the 4 month group. †Outcome of hospital admission was known for 188 infants in 4 month group (184 who completed follow-up and 4 who died), and 
for 192 infants in the 6 month group (189 who completed follow-up, 2 who died, and 1 infant who was lost to follow-up but had a documented episode of hospital admission 
before being lost). ‡This is incidence rate ratio. Primary outcome and all secondary outcomes except deaths and hospital admissions were measured at 12 months corrected age. 
Death and hospital admission data is for the entire study duration, ie, from enrolment at 4 months corrected age until final outcome assessment at 12 months corrected age.
Table 2: Primary and secondary outcomes
Articles
e508 www.thelancet.com/lancetgh   Vol 5   May 2017
[GEE] analysis, p=0·836). Mean weight (7794 vs 7846 g, 
p=0·65) at 12 months corrected age was also similar 
(appendix p 5). Additional growth data is provided in the 
appendix (pp 6–7).
Six infants died during the study period; four of 203 in 
the 4 month group versus two of 197 in the 6 month 
group (risk ratio [RR] 1·9, 95% CI 0·4–10·5; table 2). 
34 (18%) of 188 infants in the 4 month group required 
hospital admission during the study period, compared 
with 18 (9%) of 192 infants in the 6 month group (RR 1·9, 
95% CI 1·1–3·3; p=0·01), with 2·5 episodes per 
100 infant-months in the 4 month group versus 
1·4 episodes per 100 infant-months in the 6 month group 
(incidence rate ratio 1·7, 95% CI 1·0–3·0; p=0·04, 
table 2). The Kaplan-Meier curve for the time to first 
episode of hospital admission showed that the mean first 
hospital admission for the 4 month group was earlier 
compared with the 6 month group (p=0·02), with the 
risk of hospital admission 48% lower in the 6 month 
compared with the 4 month group (hazard ratio 
[HR] 0·52, 95% CI 0·29–0·92; p=0·025) during the 
study period after adjusting for randomisation group, 
site, and gestation. The results remained similar when 
multiple episodes of hospital admission for any infant 
were taken into account using the Anderson-Gill model 
(0·56, 0·33–0·94; p=0·029, figure 3).
The motor and mental development quotients in the 
two groups were similar (table 2). There was no 
significant difference in body composition, BMC, BMD, 
lipid profile, HOMA-IR, blood pressure, or serum ferritin 
between the two groups. Median serum ferritin was 
5·4 µg/dL (IQR 3·2–12·4) in the 4 month group and 
5·7 (2·5–13·3) in the 6 month group (p=0·73), with 
almost two-thirds of infants in both groups obtaining a 
result less than 12 µg/dL (table 2).
A prespecified subgroup analysis by site, intrauterine 
fetal growth category, gestational age at birth, and type of 
feeding at randomisation (breastfed, non-breastfed, 
mixed fed) did not present any difference in the primary 
outcome (table 3).
Dietary diversity was acceptable in less than two-thirds 
of infants in either group (60·1% vs 55·0%, p=0·32; 
table 4). Acceptable minimum meal frequency was 
present in most infants (93·4% vs 92·6%; p=0·75). 
However, less than two-thirds of infants were receiving 
minimum acceptable diet. A high proportion of infants 
in both groups were bottle-fed (table 4).
Discussion
Our study shows that initiating complementary feeding 
at an earlier age of 4 months compared with 6 months of 
corrected age resulted in similar WAZ scores and other 
growth outcomes, body composition, bone mineralisation 
status, iron stores (with iron supplementation), and 
markers of metabolic syndrome at 12 months corrected 
age. However, there was a higher risk of hospital 
admission in the group with earlier initiation, suggesting 
that initiation of complementary feeding at 6 months 
corrected age might be preferable to 4 months corrected 
age in infants born at less than 34 weeks of gestation.
This evidence can be considered robust, as the study 
was adequately powered to detect the outcome of interest 
and met all criteria for high internal validity: it was a 
randomised trial with groups being similar at the start, 
groups were treated similarly except for allocated 
intervention, no co-intervention was administered, the 
overall follow-up rate was high, analyses were by 
intention to treat and the outcomes were either blinded 
or objective.
To our knowledge, only one trial published earlier 
compared the effect of initiation of complementary 
feeding on growth of preterm infants. The study had 
several limitations and concluded that there was no 
difference in the anthropometric parameters between 
the two intervention groups at 12 months of age. 
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Figure 2: Change in weight for age Z score among study infants over time by study group.
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Two other studies—one in full-term, healthy and one in 
low birthweight, exclusively breastfed infants—have 
compared the effect of initiation of complementary 
feeding at 4 versus 6 months of age.18,19 Both studies 
showed that the intervention resulted in no significant 
difference in weight or length at 12 months of age, 
similar to our study. Unfortunately, we could not 
measure breastmilk intake in our study. However, we 
did note that in breastfed infants, energy intake per kg 
bodyweight (excluding breastmilk) was higher in the 
4 month group compared with the 6 month group at all 
timepoints, although it was similar among non-
breastfed infants (except for a small difference at 
6 months corrected age; appendix p 9). Since there was 
no difference in growth parameters between the two 
groups at any timepoint, it is likely that the breastfed 
infants in the 6 month group increased their breastmilk 
intake and were deriving the additional energy from 
breastmilk. Studies using robust isotopic methods have 
also shown increased breastmilk intake in full-term 
exclusively breastfed infants who continue to remain 
breastfed until 6 months of age, and decreased intake 
among those who start on complementary feeding at 
4 months of age.20,21
The overall incidence of hospital admission in the study 
population was low, but infants in the 4 month group had 
more episodes of diarrhoea and lower respiratory tract 
infections until 12 months corrected age. Although these 
might be explained by potential contamination of 
complementary foods due to inadequate hygiene,22 a 
more biological rationale should also be considered. 
Breastmilk is known to confer immunological benefits to 
infants that are especially important for preterm infants,23 
and breastmilk intake is likely to have been lower among 
infants in the 4 month group, as discussed earlier. 
Besides, the role of dietary exposures in shaping both 
short and long term immune function in infants might 
also be a factor.24,25 Little difference in growth patterns 
between the two groups with little catch up growth in 
either group might explain similar body composition and 
similar markers of metabolic syndrome between the 
groups. The mean fat mass and % fat at 12 months of 
corrected age in either group were close to that reported 
in literature, suggesting that the biology of growth among 
this group of infants is similar across settings.26 However, 
we need to be cautious with whole body DEXA as a 
measure as it is not able to accurately establish the 
aberrant adiposity that might occur.
Poor dietary practices among all study infants despite 
counselling are more difficult to understand, especially as 
available evidence suggests that counselling helps to 
improve feeding practices.27 We postulate that the 
practices would possibly have been worse without 
counselling as the indicators obtained in our study were 
better than reported in literature from similar settings.28 It 
appears that to achieve the recommended dietary 
standards in this population requires a degree of 
behaviour change at the family level that is difficult to 
achieve, and requires innovative approaches to 
supplement the counselling. It is also important to 
consider that infant factors such as taste, preference, 
ability, or interest in taking feeds and pattern of eating 
could also have contributed to the dietary patterns seen in 
the study.
4 month group 6 month group Mean difference 
(95% CI)
p value
Study site
All India Institute of Medical 
Sciences
–1·5 (1·3), n=57 –1·21 (1·4),n=54 –0·3 (–0·8 to 0·2) 0·306
Safdarjung Hospital –1·7 (1·1), n=119 –1·75 (1·2), n=122 0·05 (–0·2 to 0·3) 0·743
Kasturba Hospital –1·4 (1·1), n=9 –2·1 (1·0), n=13 0·7 (–0·2 to 1·6) 0·110
Intrauterine fetal growth category
Small for gestational age –2·1 (1·2), n=52 –2·3 (1·2), n=50 –0·2 (–0·3 to 0·7) 0·408
Appropriate for gestational age –1·4 (1·1), n=131 –1·4 (1·2), n=137 –0·03 (–0·3 to 0·2) 0·806
Gestational age at birth
<28 weeks –2·0 (1·1), n=4 –2·2 (1·9), n=6 0·2 (–2·2 to 2·7) 0·836
28–30 weeks –1·7 (1·2), n=58 –1·7 (1·4), n=67 –0·04 (–0·5 to 0·4) 0·856
31–33 weeks –1·5 (1·1), n=122 –1·5±1·1, n=116 0·002 (–0·3 to 0·3) 0·987
Feeding at complementary feeding randomisation
Breastfed –1·7 (1·1), n=95 –1·8 (1·2), n=93 0·1 (–0·2 to 0·4) 0·561
Non-breastfed –1·7 (1·4), n=33 –1·6 (1·4), n=42 –0·06 (–0·7 to 0·6) 0·846
Mixed food –1·5 (1·1), n=55 –1·4 (1·3), n=54 –0·1 (–0·5 to 0·4) 0·672
Data are mean (SD) unless otherwise specified. p values are from Student t test
Table 3: Prespecified subgroup analysis for primary outcome, weight-for-age Z score at 12 months of 
corrected age
4 month group 6 month group P-value
Bottle feeding 100/183 (54·6%) 110/189 (58·2%) 0·489
Number of food groups offered 3·7 (0·9), n=183 3·5 (1·0), n=189 0·037
Acceptable minimum dietary diversity* 110/183 (60·1%) 104/189 (55·0%) 0·321
Meal frequency
Breastfed infants 
(includes only non-liquid feeds)
4·2 (1·4), n=123 4·3 (1·6), n=118 0·762
Non-breastfed infants 
(includes both milk feeds and solid or 
semisolid feeds)
8·5 (2·1), n=60 9·0 (2·0), n=71 0·138
Acceptable minimum meal frequency
Breastfed infants (≥3) 112/123 (91·1%) 104/118 (88·1%) 0·457
Non-breastfed infants (≥4) 59/60 (98·3%) 71/71 (100%) 0·279
Minimum acceptable diet (%)† 108/184 (58·7%) 103/189 (54·5%) 0·406
Consumption of iron-rich or iron-fortified 
foods (%)
175/184 (95·1%) 174/189 (92·1%) 0·216
Consistency of complementary food-thick 182/182* (100%) 182/187* (97·3%) 0·085
Texture of complementary food-grainy 166/182 (91·2%) 167/187 (89·3%) 0·538
Data presented as number (%) or mean (SD) unless otherwise specified. P value is from χ² test or Student 
t test.*Proportion of infants receiving food from four or more food groups. †Breastfed infants who received food from 
four food groups or more, and solid, semisolid, or soft foods at least three times on previous day; non-breastfed 
infants who received at least 2 milk feeds, food from four food groups or more (not including milk), and 4 or more 
meals during the previous day.
Table 4: Dietary indicators at 12 month corrected age
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Another important concern revealed by the study is the 
greatly depleted iron stores, despite most infants having 
received iron supplementation. This is a puzzling 
finding, and since we had strictly ensured the compliance, 
it requires some explanation. Studies have shown that 
iron bioavailability from habitual Indian diets is low, due 
to high phytate and low ascorbic acid to iron ratios. 
Additionally, food matrix effect and food synergies 
specific to the local context could have been an issue.29,30 
We also presume that coadministration of iron 
supplements with food or milk could have resulted in 
decreased absorption of iron. Delayed cord clamping was 
not being practiced at any of the sites during the study 
period, and that could also be a reason in part. However, 
despite all of these postulations, this is a crucial outcome 
with a bearing on neurodevelopment of these vulnerable 
infants. Therefore, it is important to do further research 
to ascertain the adequacy of recommended doses of 
supplementation in preterm infants, factors that retard 
iron absorption, and possibly better iron preparations 
with enhanced bioavailability.
This study was done in a lower middle-income country 
setting, but we propose that the results could hold 
relevance even for high-income country settings for two 
main reasons. First, we observe that growth pattern of this 
group of infants is similar across settings, with universal 
postnatal growth restriction.31,32 In this study, the 
parameters of fat mass at 12 months of age were close to 
that reported in the literature.28 Second, the feeding or 
dietary patterns in infancy are also similar with low rates 
of exclusive breastfeeding and inadequate complementary 
feeding practices.33,34,35 However, other factors that might 
limit the generalisation of results to other settings and 
would need prior consideration include differences 
between developing and developed country settings with 
respect to the birthweight of preterm infants, prevalence 
rates of intrauterine growth restriction in the population, 
practices with respect to use of post-discharge, nutrient-
enriched formula or animal milk, breastfeeding rates, 
fortification of complementary foods, background 
infection rates, and sociodemographic factors such as 
maternal education and socioeconomic status, which 
would influence hygiene and compliance to dietary advice.
We also report that the mean postnatal age of study 
infants at intervention was 5·7 months (SD 0·3) in the 
4 month group, and 7·9 months (SD 0·4) in the 6 month 
group. Since the 4 month group did not result in 
improved outcomes but increased hospital admissions, it 
follows that 6 months of postnatal age might not be 
preferred over 6 months of corrected age for initiation of 
complementary feeding in preterm infants.
The limitations of the study are the open-label design 
and differential loss to follow-up in the two allocation 
groups. However, the outcome assessors were masked to 
the allocation groups, and the baseline characteristics of 
infants lost to follow-up in either group were similar. The 
diagnostic utility of any neurodevelopmental assessment 
at 1 year of age is also inadequate, which might also be 
considered a limitation. There is a need for longer term 
follow-up of this cohort, and reassessment of their 
growth, development, micronutrient status, and markers 
of chronic disease.
Future research should focus on identifying an 
appropriate window, if one exists, to improve the 
postnatal growth of preterm infants. There is also an 
urgent need to identify the reasons for poor dietary 
patterns and greatly depleted iron stores despite 
supplementation in the preterm infants, and test 
potential interventions and institute preventive measures 
to target the same. Long-term follow-up of such infants, 
ideally till adulthood, is highly desirable.
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